Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial)

BACKGROUND: Esophagectomy is still advised as an additional treatment for pathological T1b (pT1b) esophageal squamous cell carcinoma (ESCC) following attempted endoscopic resection (ER). ER followed with definitive chemoradiotherapy (dCRT) has shown increased quality of life as well as comparable on...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Su, Yuchen, Zhang, Xiaobin, Liu, Jun, Zhang, Hong, Li, Bin, Hua, Rong, Tan, Lijie, Chen, Hezhong, Li, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331187/
https://www.ncbi.nlm.nih.gov/pubmed/32611448
http://dx.doi.org/10.1186/s13063-020-04461-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331187/
https://www.ncbi.nlm.nih.gov/pubmed/32611448
http://dx.doi.org/10.1186/s13063-020-04461-5

Ejemplares similares